Your cart is currently empty!
Stay updated with expert insights, advice, and stories. Discover valuable content to keep you informed, inspired, and engaged with the latest trends and ideas.
-
InnoCare Announces First Patient Dosed in Clinical Trial of Soficitinib for Vitiligo
InnoCare Pharma (HKEX: 09969; SSE: 688428) announced today that the first patient has been dosed in a Phase II/III clinical trial in China evaluating its novel TYK2 inhibitor, Soficitinib (ICP-332), for the treatment of non-segmental vitiligo. ICP-332 is a Class 1 innovative drug developed in-house by InnoCare with global intellectual property rights. It is a…
-
Medicinal Diets Incorporated into Over 400 Traditional Chinese Medicine (TCM) Treatment Protocols
At a press conference held on May 15 by the National Administration of Traditional Chinese Medicine (NATCM), it was announced that medicinal diets and dietary therapy have been integrated into various TCM guidelines and protocols. More than 400 TCM treatment plans, over 50 nursing protocols, and 20 preventive care intervention guidelines formulated by the NATCM…
-
EU Says TikTok May Have Violated Digital Services Act Advertising Rules; TikTok Responds
According to the official WeChat account of the “China Chamber of Commerce to the EU,” the European Commission released a statement on May 15 indicating that TikTok may have failed to meet certain obligations under the Digital Services Act (DSA), particularly in relation to the setup of its ad library and the disclosure of information.…
Leave a Reply